LEAP-EXOSOME Trademark

Trademark Overview


On Wednesday, June 14, 2023, a trademark application was filed for LEAP-EXOSOME with the United States Patent and Trademark Office. The USPTO has given the LEAP-EXOSOME trademark a serial number of 98043097. The federal status of this trademark filing is FINAL REFUSAL - MAILED as of Friday, October 18, 2024. This trademark is owned by BioCentriq, Inc.. The LEAP-EXOSOME trademark is filed in the Treatment & Processing of Materials Services and Computer & Software Services & Scientific Services categories with the following description:

Custom manufacturing of biopharmaceutical preparations for cell and gene therapy and stem cell therapy

Testing, research, and development of biopharmaceutical preparations for cell and gene therapy and stem cell therapy; Scientific services, namely, testing, scientific research and development in the field of processes for cell and gene therapy and stem cell therapy; stem cell research services and clinical research in the field of gene therapy; consulting services in the fields of biopharmaceutical research and development and genetic science
leap-exosome

General Information


Serial Number98043097
Word MarkLEAP-EXOSOME
Filing DateWednesday, June 14, 2023
Status645 - FINAL REFUSAL - MAILED
Status DateFriday, October 18, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesCustom manufacturing of biopharmaceutical preparations for cell and gene therapy and stem cell therapy
Pseudo MarkLEAP EXOSOME
Goods and ServicesTesting, research, and development of biopharmaceutical preparations for cell and gene therapy and stem cell therapy; Scientific services, namely, testing, scientific research and development in the field of processes for cell and gene therapy and stem cell therapy; stem cell research services and clinical research in the field of gene therapy; consulting services in the fields of biopharmaceutical research and development and genetic science

Classification Information


International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateThursday, August 15, 2024
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, July 19, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBioCentriq, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNewark, NJ 07103

Trademark Events


Event DateEvent Description
Monday, July 24, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Saturday, June 17, 2023NEW APPLICATION ENTERED
Wednesday, July 19, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, July 24, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, July 24, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, January 31, 2024ASSIGNED TO EXAMINER
Wednesday, May 15, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Wednesday, May 15, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Thursday, August 15, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 15, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, August 16, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, February 15, 2024NON-FINAL ACTION WRITTEN
Thursday, February 15, 2024NON-FINAL ACTION E-MAILED
Thursday, February 15, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, October 18, 2024NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, October 18, 2024FINAL REFUSAL WRITTEN
Friday, October 18, 2024FINAL REFUSAL E-MAILED